MDS

>

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Latest News

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic factors.
Donor Lymphocyte Infusion May Improve Survival in R/R MDS

November 20th 2024

Patients with relapsed or refractory MDS may experience improved overall survival with DLI, depending on certain prognostic factors.

Illustration of blood cells.
Venclexta Regimen Beneficial for Patients with AML and MDS

November 19th 2024

Image of red blood cells.
Trial for Patients With High-Risk MDS Misses Goal, Discontinues Study

November 18th 2024

Illustration of woman with blonde hair.
Taking Time to ‘Smell the Roses’

November 14th 2024

Illustration of blood cells.
GVHD Prophylaxis Using PTCY Remains Valid Treatment Option in MDS

November 8th 2024

More News

Site Logo

Robin Roberts Returns to Good Morning America

Elizabeth Whittington
February 20th 2013

Robin Roberts, who was one of the most influential people in cancer last year, returns to "Good Morning America" today after recovering from MDS and a bone marrow transplantation.

<1
...
34567